Filter documents

pdf icon

FSRH Clinical Standards for Risk Management Jul 2014

File size: 275kb | Date: 1 July 2014 | Clinical Standards - PDF

Risk Management is an approach to improving the quality and safety of health care by identifying circumstances that put patients and staff at risk and acting to prevent or control those risks.

pdf icon

FSRH Quality Standard Contraceptive Services

File size: 614kb | Date: 1 April 2014 | Clinical Standards - PDF

A quality contraceptive service is vital in giving women and men of all ages choice and control over their reproduction, and is key to avoiding unplanned pregnancies and planning families. Contraception is a highly cost-effective intervention, which plays an important public health role in improving the lives of individuals, families and communities.

pdf icon

FSRH Clinical Standard Supporting Doctors' Appriasal and Revalidation in SRH Apr 2014

File size: 761kb | Date: 1 April 2014 | Clinical Standards - PDF

With the introduction of the process of revalidation for doctors, appraisal has been standardised and this has been supported by the Medical Appraisal Guide, Model Appraisal Form Guidance for this has already been published by the Royal College of Obstetricians and Gynaecologists and Faculty of Sexual and Reproductive Healthcare outlining what supporting evidence should be provided at appraisal.

pdf icon

FSRH CEU Statement: Oral Contraceptives and Multiple Sclerosis (March 2014)

File size: 59kb | Date: 1 March 2014 | Clinical Statements - PDF

Various news stories have reported the findings detailed in the AAN press release which stated that compared to women who did not use hormonal contraceptives, women who did, were 35 percent more likely to develop Multiple Sclerosis and that the findings suggested that hormonal contraception may be contributing to the rise in the rate of MS among women.

pdf icon

FSRH CEU Statement: St Johns Wort and Hormonal Contraception (March 2014)

File size: 102kb | Date: 1 March 2014 | Clinical Statements - PDF

St Johns wort is a herbal product that is used for depressive symptoms and is known to have enzyme-inducing effects on cytochrome p450 enzymes. The MHRA statement highlights that in the last quarter of 2013, two ‘Yellow Card’ reports were received relating to unplanned pregnancies, in women with progestogen-only implants, suspected to be the result of an interaction with St John’s wort.

pdf icon

FSRH CEU Statement: Response to new reports of link between COC and Glaucoma (November 2013)

File size: 55kb | Date: 1 November 2013 | Clinical Statements - PDF

Following a presentation at the annual meeting of the American Academy of Ophthalmology a number of media reports have reported a possible link between use of combined oral contraception (COC) and glaucoma. There is limited data investigating combined hormonal contraceptives on glaucoma. One cohort study suggested that 5 or more years of COC use was associated with a 25% increase in the risk of glaucoma. Two UK cohort studies did not find consistent evidence of an increased risk.